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ABSTRACT
Introduction: Mental healthcare organisation can
either pursue specialisation, that is, distinct clinicians
and teams for inpatient and outpatient care or personal
continuity of care, that is, the same primary clinician
for a patient across the two settings. Little systematic
research has compared these approaches. Existing
studies subject have serious methodological
shortcomings. Yet, costly reorganisations of services
have been carried out in different European countries,
inconsistently aiming to achieve specialisation or
personal continuity of care. More reliable evidence is
required on whether specialisation or continuity of care
is more effective and cost-effective, and whether this
varies for different patient groups and contexts.
Design and methods: In a natural experiment, we
aim to recruit at least 6000 patients consecutively
admitted to inpatient psychiatric care in Belgium,
Germany, Italy, Poland, and the UK. In each country,
care approaches supporting specialisation and personal
continuity coexist. Patients will be followed up at 1 year
to compare outcomes, costs and experiences.
Inclusion criteria are: 18 years of age or older; clinical
diagnosis of psychosis, affective disorder or anxiety/
somatisation disorder; sufficient command of the
language of the host country; absence of cognitive
deterioration and/or organic brain disorders; and
capacity to provide informed consent.
Ethics and dissemination: Ethical approval was
obtained in all countries: (1) England: NRES
Committee North East—Newcastle & North Tyneside
(ref: 14/NE/1017); (2) Belgium: Comité d’Ethique
hospitalo-facultaire des Cliniques St-Luc; (3) Germany:
Ethical Board, Technische Universität Dresden; (4)
Italy: Comitati Etici per la sperimentazione clinica
(CESC) delle provincie di Verona, Rovigo, Vicenza,
Treviso, Padova; (5) Poland: Komisja Bioetyczna przy
Instytucie Psychiatrii i Neurologii w Warszawie. We will
disseminate the findings through scientific publications
and a study-specific website. At the end of the study,
we will develop recommendations for policy decision-
making, and organise national and international
workshops with stakeholders.
Trial registration number: ISRCTN registry:
ISRCTN40256812.
INTRODUCTION
A central question in mental healthcare is
whether to prioritise specialisation of clini-
cians and clinical teams or personal continu-
ity of care.1–4 These two care approaches are
sometimes incompatible as each one requires
a different organisation of care.1 5
Following the specialisation approach,
mental healthcare should be provided by dif-
ferent clinicians and teams in inpatient and
outpatient settings. This care approach is
expected to simplify the practical organisa-
tion of services; support quick clinical
decision-making; enable clinical teams and
clinicians to have a full focus on only one
Strengths and limitations of this study
▪ This study will be the largest one comparing
care approaches based on specialisation and per-
sonal continuity of care worldwide.
▪ It will involve services across five European
countries and comprehensively assess out-
comes, costs and experiences of the ‘specialisa-
tion’ and ‘personal continuity’ care approaches.
▪ The natural experiment methodology has the
advantage of allowing comparisons of the two
approaches without altering already established
routine provision of care.
▪ Being a natural experiment, patients will not be
randomised to either approach. Clustering in out-
comes may be found within hospitals and coun-
tries. We will explore random effects for
hospitals using mixed regression models.
▪ Selection bias at baseline and attrition at
follow-up are common pitfalls in large prospect-
ive studies on people with severe mental disor-
ders. We will attempt to: (1) minimise selection
bias through approaching all patients within a
few days from a hospital admission; and (2)
reduce attrition using medical records or brief
phone interviews to collect the main outcome
data.
Giacco D, et al. BMJ Open 2015;5:e008996. doi:10.1136/bmjopen-2015-008996 1
Open Access Protocol
setting; and foster an expertise in setting speciﬁc aspects
of treatment.1 6
According to the personal continuity of care
approach, however, the same primary clinician is respon-
sible for a given patient within both inpatient and out-
patient settings. This approach may facilitate the smooth
transition of patients from one setting to another;
support long-lasting therapeutic relationships; and sim-
plify clinical communication as patients and clinicians
are familiar with each other across the care settings.2 3 7
The expected beneﬁts of specialisation and personal
continuity of care are summarised in table 1.
Yet, solid evidence on which of these two approaches
is associated with better outcomes is lacking. As a conse-
quence, service reorganisations are inconsistent across
Europe and the issue repeatedly raises debate.3 8–10
In the UK, although the organisation of mental
healthcare traditionally favoured personal continuity of
care,3 7 most provider organisations of mental health-
care (ie, NHS Trusts) have now established specialised
hospital and community teams.5 11 12
In Germany, the traditional approach has been charac-
terised by specialisation of clinicians and teams, while
recent initiatives (‘Integrierte Versorgung’, ie,
‘Integrated healthcare’) have aimed to strengthen con-
tinuity of care and to make one service responsible for
both inpatient and outpatient care.2 4
In various other European countries (eg, Austria,
Belgium, Denmark, France, Italy, Netherlands, Norway,
Poland, Sweden, Switzerland) similar experimental pro-
grammes and professional debates are currently ongoing
to change traditional mental healthcare approaches13–20
(see ﬁgure 1).
A systematic review comparing approaches based on
specialisation or personal continuity of care found there
was a general tendency towards better outcomes and
patient/clinician preferences for approaches prioritising
personal continuity of care.21 However, most studies had
serious methodological shortcomings and deﬁnitive con-
clusions could not be drawn.
The studies included in the review shared the follow-
ing limitations:21
A. They were conducted in local settings.
B. Their samples were not large enough to detect small
differences in outcomes between care approaches.
Yet, small differences, for example a reduction of 5%
in the number of re-hospitalisations, may have a sig-
niﬁcant impact on a national scale.
C. The studies have assessed only a limited range of out-
comes, disregarding outcomes like patient safety and
cost-effectiveness.
D. All the studies compared a newly implemented care
approach (either favouring specialisation, eg, in the
UK or personal continuity of care, eg, in Germany)
with the traditional approach. With the exception of
patient experiences and preferences, which were
consistently in favour of care approaches supporting
personal continuity of care,5 22 other outcomes were
always positive for the new experimental approach
irrespective of the type (‘novelty bias’).21
To address the limitations of the available studies, we
have designed a natural experiment comparing
approaches favouring either specialisation or personal
continuity of care in ﬁve European countries (Belgium,
Germany, Italy, Poland and UK). In all these countries,
both approaches to care exist within routine practice.
Mental healthcare approaches were categorised based
on whether a patient has the same ‘primary clinician’
for their inpatient and outpatient care or not. The
‘primary clinician’ is the clinician who is primarily
responsible for the patient (usually a psychiatrist or a
psychologist). The two approaches were operationalised
as follows:
▸ ‘Specialisation approaches’ are those in which differ-
ent primary clinicians are responsible for the treat-
ment of a patient, depending on whether the patient
is in the inpatient or outpatient care.
Figure 1 National reforms and changes in mental healthcare
organisation.
Table 1 Expected benefits of specialisation and personal continuity of care
Areas Specialisation Personal continuity of care
Organisational aspects at
a service level
Quick clinical decision-making;
positive risk management
No fragmentation of services; increased engagement with
patients who are less likely to actively seek treatment
Clinical benefits Specialisation of interventions Continuity of care
Impact on routine care Enhancement of clinical leadership
and specialised expertise
Establishment of a stronger therapeutic relationship
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▸ ‘Personal continuity approaches’ are those in which
the same primary clinician is responsible for both
inpatient and outpatient care of a patient.
This study was funded by the 7th Framework
Programme of the European Commission (Full title:
Comparing policy, framework, structure, effectiveness
and cost-effectiveness of functional and integrated
systems of mental health care—COFI).
COFI will be the largest study comparing specialisation
and personal continuity of care, reaching more patients
than all of the previous studies combined. The study will
involve a comprehensive assessment of outcomes, cost-
effectiveness and patient/clinician experiences. It will
include services in which specialisation or personal con-
tinuity approaches are the standard way of providing
mental healthcare, rather than experimental
programmes.
The comparison of the two approaches will be
carried out in a wide range of settings, and in coun-
tries with different traditions and practices of mental
healthcare. ‘Specialisation’ and ‘personal continuity’
approaches are supported in these different countries
by a variety of funding mechanisms, policies and clin-
ical arrangements. This will allow for the generalis-
ability of our ﬁndings from the participating
countries to a higher number of countries with
similar characteristics.
AIMS AND OBJECTIVES
COFI aims to compare outcomes, costs and experiences
of ‘specialisation’ and ‘personal continuity’ of care
approaches.
Readmission to hospital was chosen as the primary
outcome of the study due to the high clinical relevance
and impact on service costs. The validity of readmission
rates as an outcome criterion for mental health service
evaluation has been conﬁrmed in previous studies.23 24
COFI will address the following research questions:
A. Primary research question
▸ Do rates of rehospitalisation differ between the spe-
cialisation and personal continuity approaches?
Figure 2 Hospitals included in
the study.
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B. Clinical and social outcomes
▸ Is there a difference in number of voluntary and
compulsory rehospitalisations per patient and yearly
inpatient bed days between the two approaches?
▸ Are untoward incidents (deaths, suicides, physical
violence committed or experienced by patients)
more frequent in either approach?
▸ What are the social outcomes, in terms of employ-
ment, accommodation, living situation, subjective
quality of life and social contacts of patients treated
by either approach?
C. Costs of care:
▸ What are the direct costs of care (ie, related to use
of services) within each approach?
▸ Which approach is most cost-effective?
D. Experience of care
▸ What are treatment satisfaction and experiences of
care provided by the two approaches and do they
differ?
We will also carry out comparisons of the two
approaches in subgroups of patients deﬁned by age,
gender, diagnosis, ﬁrst admission, socioeconomic situ-
ation, migrant status and presence of physical
comorbidities.
We hypothesise that:
▸ The ‘specialisation approach’ may be more effective in
providing specialised care for people with less complex
and more speciﬁc mental health needs (eg, absence of
comorbid disorders or social problems), who do not
require coordination of different interventions.1 12
▸ The ‘personal continuity approach’, ensuring a stron-
ger coordination of different interventions,7 25 may
be more suited for treating patients who are affected
by severely disabling mental health conditions (eg,
schizophrenia) and comorbid physical illnesses, or
those who have complex psychosocial needs such as
patients with a low socioeconomic status, migrants
and patients with comorbidities.
DESIGN AND METHODS
Study design
COFI is a natural experiment, prospectively following up
for 1 year patients who, at the point of entry in the
study, are hospitalised within care services adopting
either a ‘specialisation’ or ‘personal continuity’
approach. Participating sites are located in ﬁve countries
(Belgium, Germany, Italy, Poland and UK). In these
countries both approaches are present, although prac-
tice, traditions, policies and funding of mental health-
care vary signiﬁcantly.
Each included patient can only be treated within
either a ‘specialisation’ or ‘personal continuity’ care
approach, and the exposure of patients to either
approach is outside of the control of investigators and
hence, naturalistic. Allocation to either model is based
on the given organisation of care in a deﬁned geograph-
ical area (UK, Italy), on a clinical decision and patients’
choice (Belgium, Poland), or on insurance arrange-
ments (Germany).
The methodology of a natural experiment has the
main advantage of allowing comparisons of the two
approaches without altering already established routine
provision of care.
However, this implies that no randomised allocation of
patients to different approaches is possible. Given the
risk of bias associated with a non-randomised design,
adjustment for potential confounders is of paramount
importance.26 In our study, potential confounders will
be adjusted for by exploring random effects at a hospital
level which will provide an estimate of the potential vari-
ability of practice and outcomes both within countries
and in different services within the countries.
Settings
COFI is coordinated by the Unit for Social and
Community Psychiatry, Queen Mary University of
London (QMUL). QMUL is responsible for data collec-
tion in 11 provider organisations, that is, National
Health Service (NHS) Trusts, in the UK as well as for
overall project management.
Collaborating academic centres which are responsible
for data collection in the remaining four countries are:
(1) University of Louvain (Belgium); (2) Technische
Universität Dresden (Germany); (3) University of
Verona (Italy); (4) Institute of Psychiatry and Neurology
of Warsaw (Poland). In each country, at least four hospi-
tals in which a ‘specialisation approach’ is used and four
hospitals in which a ‘personal continuity approach’ is
used will be included in data collection. In Belgium,
Germany and Poland, patients treated under ‘specialisa-
tion’ and ‘personal continuity’ of care approaches can
be admitted to the same hospital as organisation of care
is based on insurance arrangements or clinical decisions
for the individual patients.
The hospitals in which patients are recruited are
spread throughout the participating countries (see
ﬁgure 2).
.
Participants
Inclusion criteria
(1) 18 years of age or older; (2) clinical diagnosis of
psychotic disorder (F20–29), affective disorder (F30–39)
or anxiety/somatisation disorder (F40–49)
(International Classiﬁcation of Diseases—ICD—10);27
(3) being hospitalised in a general adult psychiatric
inpatient unit; (4) sufﬁcient command of the language
of the host country to provide written informed consent
and understand the questions in the research interviews;
(5) capacity to provide informed consent.
Exclusion criteria
(1) Diagnosis of organic brain disorders; (2) too severe
cognitive impairment for providing information on the
study instruments.
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Baseline measures
At baseline, we will collect data on:
A. Sociodemographic characteristics: year of birth,
gender, marital status, highest completed education
level, country of birth;
B. Social situation: employment, accommodation, living
situation, friendships, self-reported beneﬁts receipt
due to low income;
C. Psychiatric and non-psychiatric diagnoses according
to the International Classiﬁcation of Disease 10
(ICD-10);27 the primary clinical diagnosis is estab-
lished from medical records or clinician’s report at
discharge from hospital;
D. Severity of illness, rated by treating psychiatrists by
the Clinical Global Impression Scale (CGI);28
E. Whether the current admission is the ﬁrst one or
not;
F. Formal status at admission (involuntary/voluntary);
G. Patient appraisal of inpatient care, as measured by
the Client Assessment of Treatment (CAT).29
Follow-up measures
In the one-year follow-up, we will compare ‘specialisa-
tion’ and ‘personal continuity’ of care approaches with
reference to:
Primary outcome
▸ Readmission to hospital.
Other clinical and social outcomes
A. Clinical outcomes including: (1) number of readmis-
sions; (2) number of compulsory readmissions; (3)
inpatient bed days, using an ad hoc schedule based
on the Client Service Receipt Inventory.30
B. Social outcomes, based on the SIX index,31 which cap-
tures: (1) employment (none; voluntary or protected
or sheltered work; regular employment); (2) accom-
modation (homeless or 24 h supervised; sheltered or
supported accommodation; independent accommo-
dation); (3) living situation (living alone; living with
a partner or family); (4) contacts with friends (not
having met a friend within the past week; having met
at least one friend in the past week).
C. Subjective quality of life, measured by the Manchester
Short Assessment of quality of life MANSA.32
D. Untoward incidents related to mental healthcare, includ-
ing: (a) deaths; (b) completed suicides; (c) serious
assaults committed by patients; (d) physical violence
experienced by patients; (e) suicide attempts; (f)
serious side effects from pharmacological treatment
requiring hospitalisation, as extracted from clinical
records or obtained through phone interviews.
E. Social contacts, measured as: (a) the total number of
social contacts within the week preceding the assess-
ment as reported by patients using an ad hoc instru-
ment, adapted from the Social Network Schedule,33
and (b) whether or not they declare to have at least
one close friend, using the speciﬁc item on the
MANSA.32
F. Experienced discrimination, measured as: (a) patient-
reported episodes of discrimination because of
mental illness, and (b) patient-reported avoidance of
activities because of fear of discrimination, measured
by ad hoc items.
G. Perceived socioeconomic status, that is, patient self-rated
standing in his/her own self-deﬁned community and
country, measured by the MacArthur Scale of
Subjective Social Status.34 35
Costs
Service use will be measured using an adapted version
of the Client Service Receipt Inventory.30 This will
include details of:
A. In-patient bed days;
B. Contacts with outpatient services;
C. Contacts with day centres;
D. Contacts with other community services.
We will then calculate unit costs for each service and
for the different countries in order to translate service
use data into costs of care.
Experience of care
A. Satisfaction with care, measured by the 32-item version
of the Verona Service Satisfaction Scale (VSSS-32).36
B. Experienced continuity of care, explored by a set of
questions designed during the study preparation
phase. The questions explore: a) whether patients,
following discharge, have met any of the psychiatrists
or other mental health professionals that they saw in
hospital; b) if yes how many psychiatrists or mental
health professionals and what type of professionals;
c) how long was it in weeks between hospital dis-
charge and ﬁrst outpatient contact; and d) whether
they feel this duration was too long, too short or just
right.
Qualitative semistructured interviews will explore the
in-depth experience of providing care (clinicians) and
receiving care (patients) within specialisation or con-
tinuity of care approaches. Topic guides are being devel-
oped to constitute a discussion guide for the interviews.
These are based on the same set of themes and topics
for patients and clinicians:
1. Transition between hospital and outpatient services: admis-
sion to hospital; discharge and transition between
hospital and outpatient treatment; transition between
different outpatient settings.
2. Continuity of care: management/coordination of treat-
ment; staff behaviour and skills; sharing of informa-
tion between different professionals; provision of
information to patients.
3. Patients’ and carers’ involvement: patients’ and carers’
involvement in treatment planning; how patients’
and carers’ preferences are reﬂected in the choice of
speciﬁc settings, services and treatment options.
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4. Accessibility and availability: appropriateness and timeli-
ness of care provided; cooperation of mental health
services with other healthcare services and with social
services.
Procedures
Establishing exposure to ‘specialisation’ or ‘continuity’ of
care approach
To reﬂect differences in how mental healthcare services
operate in the ﬁve countries, different procedures are
used to ascertain exposure status to either a ‘specialisa-
tion’ or ‘personal continuity’ of care approach.
In the UK and in Italy, all patients admitted to the
same hospital are treated under the same care
approach, either a ‘specialisation’ or ‘personal continu-
ity’ approach. In these countries, the local providers of
care, that is, an ‘NHS Trust’ in UK and a ‘Dipartimento
di salute mentale’ in Italy, may follow either the ‘special-
isation’ or ‘personal continuity’ of care approach. The
care is organised in the same way for all patients treated
by the same provider of care which operates in a speciﬁc
geographic area.
In Belgium, Germany and Poland, patients admitted
to the same hospital can be treated under either a ‘spe-
cialisation’ or a ‘personal continuity’ of care approach.
This is determined by patients’ health insurance
arrangements (Germany) and/or by a mental health
team decision in which the patient may or may not be
involved (Belgium, Poland and Germany). Therefore, a
patient is included in either group based on the primary
hospital clinician report at discharge in Belgium, Poland
and Germany.
Recruitment, obtaining informed consent and baseline
interviews
Patients consecutively admitted to participating hospitals
in each country from 1 October 2014 to 31 December
2015 are screened within two days of admission and
recruited in the study. Patients will be followed-up for
1 year following their entry into the study. The end of
follow-up is planned by 31 December 2016.
An internal pilot of study procedures was conducted
from July 2014 to September 2014 and showed that
study procedures are feasible.
First contact between the patient and the research staff
takes place within two working days from the hospital
admission to minimise potential selection bias due to early
discharge of some patients, and to standardise the period
of patient experience in the hospital. However, to ensure
that as many eligible patients as possible are recruited and
to increase the representativeness of the sample, there is
some ﬂexibility in recruitment. The initial contact can be
postponed until the discharge if the patient wishes, or he/
she is deemed to be too unwell by the clinician in charge.
Before the patient is contacted by the researcher,
a clinician will ask the patient for his/her assent to partici-
pate in research. If assent is obtained, the clinician intro-
duces the researcher to the patient. The researchers
explain the study and obtain written informed consent for
participation in the study from the patients in face-to-face
meetings. Any reason for which the interview is not con-
ducted within two working days from the admission will be
documented.
To enable an accurate estimation of selection bias, any
pause in the recruitment (eg, for holidays or if all the
researchers are on leave at the same time or for any
other organisational reason) will be documented by spe-
cifying each day of recruitment and non-recruitment.
The overall COFI recruitment and data collection
plan is reported in ﬁgure 3.
Data collection at one-year follow-up
Clinical outcomes, employment, accommodation, living
status, friendships, untoward events and indicators of
care costs will be followed up for the entire sample via
medical records or telephone contact.
To assess patients’ subjective quality of life, global
social contacts, experienced and anticipated discrimin-
ation, perceived socioeconomic status, satisfaction with
care, contacts with primary and secondary care profes-
sionals, and for patients’ experienced continuity of care
we will randomly select a subsample of patients, who will be
interviewed face-to-face.
Patients and clinicians interviewed for the qualitative
study will be purposively selected from among those
included in the entire sample. Selection criteria are
reported in the following paragraph.
Sample size determination
The sample size for the quantitative study was calculated
with the aim to detect a 5% difference in rates of re-
admissions (ie proportion of patients re-hospitalised
during the one year follow up) between the two care
approaches from 27.5% to 32.5% with 80% power at the
5% signiﬁcance level.
The sample size required for an individual-level com-
parison not considering clustering of outcomes within
centres and hospital would be 2716 patients.
We calculated an average cluster size per hospital of
150 patients recruited over one year. Taking into
account a 15% drop out rate, the average number per
hospital of patients recruited and followed up will be
128. The variance inﬂation factor (or design effect, IF)
is given by IF=1+(m−1)×ρ; where m=cluster size, and
ρ=ICC (inter-cluster correlation coefﬁcient). The ICC in
a cluster with such a large number of patients is
expected to be very small.37 With m=128 and ρ=0.007, IF
is 1.90, and the adjusted sample size is N=5162 (1034
per country), requiring eight hospitals per country with
an average number of 150 patients recruited per hos-
pital, ie 1200 patients per country and 6000 overall.
We will carry out follow-up face-to-face interviews with
a subsample of patients who will be 18–65 years of age.
The patients will be stratiﬁed based on diagnostic group
(ICD codes: F20–29, F30–39, F40–49)27 and on whether
the index admission was their ﬁrst one or they have had
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previous hospital admissions. We will aim to interview
30 patients per stratum, resulting in 360 patients per
country (60×6 clusters) and an overall sample of 1800
patients (360×5 countries).
For the in-depth interviews, we will purposively select
40 patients and 13 clinicians in each country, resulting
in a total sample of 200 patients and 65 clinicians.
Within the sample, there will be a mix of: (1) patients
treated with ‘specialisation’ and ‘personal continuity’ of
care approaches; (2) those who were rehospitalised during
the follow-up and those who were not; and (3) patients
with different diagnoses (F20–29, F30–39, F40–49).
Clinicians will be included taking into account: (1) the
care approach (‘specialisation’ or ‘personal continuity’)
adopted by the service they work within and (2) their
qualiﬁcation: psychiatrists, psychologists, nurses/social
workers.
DATA ANALYSIS PLAN
Adjustment for confounders
The coexistence of the two care approaches in the ﬁve
participating countries may be considered a major
strength of the present study. Yet, clustering in outcomes
may be found within hospitals and countries; therefore,
we will explore random effects for hospitals as part of
mixed regression models.
Analysis of clinical and social outcomes
Mixed effects models with an unstructured variance
matrix will be used to assess differences in the primary
outcome (rehospitalisation), and in the other clinical
and social outcomes between the two groups. We will
explore random effects for the hospitals or ‘specialisa-
tion’ and ‘personal continuity’ of care clusters within
the hospital (in Germany, Belgium and Poland), and
use ﬁxed effects for the following covariates:
▸ Age, gender, diagnostic group, whether or not a
patient has been previously admitted, severity of
illness at baseline, social situation (SIX score) and
formal status of the patient at baseline.
We will check the selection bias by comparing data of
our sample with the aggregate data for the total group
of admitted patients during the same period.
Potential mediators of effectiveness may be: (1) the
intensity of treatment, that is, sum of inpatient days and
outpatient visits; (2) the experience of hospital care
within the index admission, which has been shown to be
predictive of better outcomes following discharge.38 39
A higher intensity of treatment or a better experience of
hospital care may occur in either the ‘specialisation’ or
the ‘personal continuity’ of care approach and be
responsible for better outcomes.21 38 We will develop a
mediation model40 in order to identify and explicate a
potential effect of intensity of treatment and/or experi-
ence of hospital care during the index admission for
assessing the effectiveness of the two approaches.41
Exploratory analyses to compare clinical outcomes,
social outcomes and untoward events between the ‘spe-
cialisation’ and ‘personal continuity’ of care approaches
will also be carried out on subgroups of patients
deﬁned by:
▸ Age (younger or older than 40 years);
▸ Gender (males or females);
▸ Primary psychiatric diagnosis (F20–29 or F30–39 or
F40–49);
▸ First or repeated admission;
▸ Socioeconomic situation (receiving state beneﬁts due
to low income or not);
▸ Migrant status (ie, country of residence different
from country of birth or not);
▸ Presence of physical comorbidity/comorbidities for
substance use, diabetes, cardiovascular diseases or
not.
All subgroup analyses will be performed by including
the relevant variables as interaction terms in the models.
Analysis of costs
The economic analysis will be led by the Centre for the
Economics of Mental and Physical Health at King’s
College London. Unit costs for each service measured
with the CSRI will be calculated for each country. In order
Figure 3 COFI recruitment and
data collection plan. COFI,
Comparing policy, framework,
structure, effectiveness and
cost-effectiveness of functional
and integrated systems of mental
healthcare.
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to compare costs across countries with different curren-
cies, purchasing-power parities will be used to transform
the country-speciﬁc costs into a single currency, thus allow-
ing for analysis of the total sample as well as cross-national
comparisons. The likely different impact of cost external-
ities or different cost structure of the two care approaches
will be evaluated. Multiple regression will be used to adjust
for the baseline patient characteristics in all tests of differ-
ences in costs and clinical outcomes. Cost-effectiveness will
be then explored through the calculation of incremental
cost-effectiveness ratios (ICER), deﬁned as the difference
in mean costs divided by difference in mean effects.
Analysis of experience of care
The analysis of patient satisfaction with care and per-
ceived continuity of care measured through quantitative
methods will follow similar procedures to those
described in the ‘analysis of clinical and social out-
comes’ paragraph.
Data from semistructured interviews with patients and
clinicians will be audio taped and transcribed verbatim,
ensuring the removal of any identifying information to
maintain anonymity. Transcripts will be analysed through a
thematic content analysis method.42 Study centres in each
country will generate a list of emerging codes based on a
line-by-line analysis of the ﬁrst three interviews with
patients and ﬁrst two with clinicians in the respective
country.43 Consistency of coding will be assessed across all
centres. First, researchers at the Institute of Psychiatry and
Neurology of Warsaw (IPIN) and at Queen Mary
University of London (QMUL) will screen the databases
containing the coding results of the ﬁrst interviews in each
centre and discuss any discrepancies with the relevant
centre. Second, researchers from all centres will provide
further veriﬁcation and clariﬁcation of the meanings of
the codes during a one-day workshop. Third, each partner
will code two interviews with patients and two interviews
with clinicians (conducted in English or translated into
English), and researchers at IPIN and QMUL will assess
the coded data for discrepancies. Separate codebooks will
be developed for interviews with patients and with clini-
cians, and interviews will be coded based on these.
Codes will be categorised based on their English trans-
lations. To obtain meaningful themes, the emerging cat-
egories and codes will be organised and grouped.
Researchers from all centres will verify the emerging cat-
egories and themes to ensure consistency across the data
set. Descriptive counts of themes, categories and codes
will be use to summarise the data set.
QMUL group is experienced in conducting qualitative
analyses of data from different countries as they have
already led previous similar studies in which IPIN was
also involved.44 45
Secondary analysis based on continuity of care as a
‘continuum’
A wide variability of care arrangements may support spe-
cialisation of clinicians and teams or personal continuity
of care. This may determine intragroup differences
among the services included within the categories of
‘specialisation’ and ‘personal continuity’ of care
approaches. For example, the presence of a ‘care coord-
inator’ may guarantee continuity of care even when
there are two different primary clinicians in the hospital
and in the community. On the other hand, even when
patients have the same primary clinician in the hospital
and in the community, they may be treated for short
periods of time by ‘specialist services’ such as home-
treatment teams, emergency wards or psychiatric inten-
sive care units led by different primary clinicians.
We will investigate the variety of system characteristics
that lead to the implementation of specialisation and
personal continuity of care in the ﬁve participating
countries. This part of the study will focus on the ﬁnan-
cial and healthcare governance mechanisms that
support both care approaches and will be led by the
University of Louvain.
To explore this in more depth, we will also develop an
instrument assessing continuity of care as a continuum.
We will use this instrument to identify and rate different
care arrangements within the two alternative
approaches.
The association between different levels of continuity
of care and the outcomes will be tested through mixed
models taking into account random effects at an hos-
pital level and ﬁxed effects of the same covariates
described above for the primary analysis.
DISCUSSION
COFI is a natural experiment which will overcome
limitations of the currently available evidence:
A. It is a multicentre study carried out in countries with
very different traditions, funding mechanisms and
policies for mental healthcare. In all these countries,
care approaches supporting either specialisation or
personal continuity of care coexist. This will allow for
comparisons to be made within a similar context and
not be confounded by country-speciﬁc character-
istics. The service arrangements supporting special-
isation or personal continuity of care may vary
substantially among the countries, which will make
our ﬁndings more robust and increase their general-
isability to other countries and contexts.
B. It is powered to detect very small differences in clin-
ical and social outcomes between the two care
approaches assessed that are relevant from a policy
decision-making point of view (eg, 5% in rates of
rehospitalisation).
C. A comprehensive range of outcomes will be assessed,
encompassing clinical outcomes, social outcomes,
safety of care indicators, patient satisfaction with ser-
vices and cost-effectiveness.
D. Care approaches supporting specialisation or per-
sonal continuity of care which are assessed in this
study are already established as routine services and
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are not just pilot experimental services. This will be a
methodological safeguard from the ‘novelty bias’
found in the existing literature in which the newly
established approaches (either supporting specialisa-
tion or continuity of care) tend to have better out-
comes than the traditional ones.21
Advantages of the adopted methodology
COFI will be the ﬁrst natural experiment to compare dif-
ferent approaches to routine mental healthcare
provision.
Natural experiments have a number of advantages
over randomised controlled trials in health service
research.46–49
From a practical point of view, the costs related to
reorganisation of the mental healthcare services in mul-
tiple areas of a country for an experimental trial would
not be sustainable or feasible. With a natural experiment
design, a high number of patients can be recruited and
the effectiveness of different care approaches can be
assessed in different areas with no excess treatment
costs.
From a scientiﬁc point of view, an assessment of rou-
tinely provided care avoids the ‘novelty bias’ related to
the enthusiasm of patients and clinicians for a newly
established way of receiving or providing care.21 Patients
will be receiving and evaluating standard care instead of
a new intervention.
The choice of the sites is very important for a natural
experiment. The clinical sites recruited reﬂected a wide
range of geographical areas. The ﬁve participating coun-
tries have both care approaches as part of their routine
mental healthcare provision in different cities or areas
of a different city; therefore, the comparison will not be
biased by within-country variables. Potential clustering of
outcomes will be explored considering random effects at
a hospital level.
The countries selected for COFI offer a wide variety of
traditions, policy models and funding mechanisms
of mental healthcare. They are located in different areas
of Europe and share commonalities in sociopolitical
characteristics as well as practice and organisation of
mental healthcare with non-included neighbouring
countries. Therefore, it is expected that COFI ﬁndings
can be generalisable to a larger number of countries in
Europe than those included in the study.
Potential challenges
Patients will be recruited during the ﬁrst days of hospital
admission. Many patients may not be able to give
consent or, even if they are, be unwilling to participate
in the study because they are severely distressed. A
number of patients admitted during the weekend and
discharged after a few days may be difﬁcult to contact.
In order to enable researchers to promptly screen all
admitted patients, we have established close links with
the hospital staff. Presentations/refreshers on the study
at all sites are carried out to make sure that all the
clinical staff in the hospitals are informed on the study
and information on new admissions is quickly passed on
to the researchers.
One important challenge for the follow-up relates to
the different ways in which medical records are stored in
different countries. In UK and Italy, continuous elec-
tronic medical records, including information on a
given patient within and outside the hospital, are avail-
able; however, this is not the case in other countries.
Therefore, patients will receive short phone interviews at
follow-up in Germany, Belgium and Poland. This may
determine attrition rates higher than 15% for the
primary outcome in these countries; in UK and in Italy,
attrition rates are likely to be lower than 15%. The
potential imbalance in missing data at follow-up among
countries will be controlled in the mixed model adjust-
ing for ﬁxed effect of baseline patient-level variables and
random effects at a hospital level.
Expected outputs
The dissemination of COFI results will not only follow
the usual pathway of publications in scientiﬁc journals
but also take advantage of electronic means of commu-
nication (newsletters, twitter, website and online
journals).
Moreover, to facilitate the translation of ﬁndings into
national mental healthcare policies and practices, we
will: (1) produce recommendations for policy decision-
making based on study ﬁndings; (2) organise workshops
inviting all relevant stakeholders.
Recommendations on policy decision-making will be
circulated to different stakeholders: (1) national govern-
ments; (2) professional associations; (3) carers and users
groups; (4) opinion leaders, managers and policymakers
at a national level. The stakeholders will be able to famil-
iarise with study ﬁndings in order to make their contri-
bution in translating research evidence from COFI into
the practice of policy decision-making.
The organisation of national workshops in all the par-
ticipating countries and of one European workshop to
discuss COFI ﬁndings will allow direct contact with stake-
holders. Such events will offer opportunities for feed-
back, as well as for the creation of strong relationships
with stakeholders and interest groups that will enhance
the impact of study ﬁndings on national mental health
policies.
CURRENT STUDY STATUS
In June 2015, COFI is in the ninth recruitment month
(out of 15 months). During the study period, 13 916
patients were admitted in the included hospitals. Among
them, 8153 were eligible for the study (58.6%); 4484 of
the eligible patients gave informed consent to partici-
pate in the study (55%). Eligibility and opt-in rates are
similar to previous studies on hospitalised patients38 50
and the current recruitment rate is in line with the
planned recruitment target (6000).
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